BPC-157
Synthetic peptide derived from a stomach protein. Used to speed up tendon, ligament, and gut healing.
BPC-157: Synthetic peptide derived from a stomach protein. Used to speed up tendon, ligament, and gut healing. Think of BPC-157 as a healing accelerator for connective tissue.
Think of BPC-157 as a healing accelerator for connective tissue. Most users run it for stubborn tendon, ligament, or gut problems where regular rehab has stalled. You inject a tiny amount under the skin once a day for 4-6 weeks, take a break, then reassess.
Compounding pharmacies may prepare under physician prescription (post Feb 2026 reclassification, pending formal FDA publication).
Not prescribed in conventional medicine. Some compounding pharmacies and longevity clinics offer it off-label.
Who it's for
- →Lifters with nagging tendon or joint pain
- →Anyone recovering from a soft-tissue injury
- →People dealing with gut issues (oral form)
What to expect
- Week 1
Often nothing yet, sometimes mild head-rush at injection.
- Week 4
Most users notice the original injury feels notably less reactive.
- Week 8
Full effect for the cycle. Plateau, then take a break.
Looking at BPC-157? Your next 3 steps
- 1Work out your exact dose
Vial size + BAC water turns into the exact units to draw for BPC-157.
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account saves your stack; membership adds the stack-aware AI Coach.
Create free account →
How it works (mechanism)
Promotes angiogenesis (new blood vessel growth) and accelerates fibroblast / endothelial cell migration to injury sites. Also modulates the nitric oxide pathway and protects against gut-wall damage. Most effects appear at the local injection site rather than systemically.
Dosing protocol
Stacks well with
Stack essentials
Side effects
When NOT to use
- ⚠Active malignancy (theoretical)
- ⚠Pregnancy / nursing (no data)
Common mistakes
- • Running it indefinitely instead of cycling
- • Underdosing (under 200mcg often blunts the response)
- • Leaving reconstituted vial at room temp longer than 7 days
Drug & supplement interactions
- ⚠Limited documented drug interactions
- ⚠Some users report compounded effect with NSAIDs (no published data)
- ⚠Theoretical caution with pro-angiogenic compounds in malignancy contexts
The Pepdex take
Pepdex take: 250mcg/day for 5 weeks is the sweet spot for chronic shoulder. Minor change by week 3, real change by week 5. Bilateral injection near the joint outperforms distal abdominal injection in community reports, the local-injection question is still debated in the literature, but for tendon work, near-the-injury wins for most users. Don't bother running below 200mcg, it doesn't crack the threshold reliably.
Community patterns
New to BPC-157? Grab the starter checklist.
Drop your email and we'll send the one-page first-cycle starter checklist, plus a heads-up if BPC-157 changes legal status. No account needed.
No spam. No selling your email. Just the checklist and the occasional reclassification alert.
Ask the Coach anything about BPC-157 or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Get the Coach, $7.99/mo →Frequently asked
What is BPC-157?+
Is BPC-157 FDA approved?+
Is BPC-157 legal?+
Is BPC-157 banned by WADA?+
Are you still natty after taking BPC-157?+
Do doctors prescribe BPC-157?+
What's the typical dose of BPC-157?+
What are the side effects of BPC-157?+
How long until BPC-157 starts working?+
What can you stack with BPC-157?+
Where do people get BPC-157?+
BPC-157 vs TB-500, which is better?+
BPC-157 vs GHK-Cu, which is better?+
Head-to-head with BPC-157
More in Healing
A fragment of Thymosin Beta-4. Drives cell migration and tissue repair, used for chronic soft-tissue stuff.
A bone-building drug. A parathyroid-hormone fragment (PTH 1-34), FDA-approved as Forteo for severe osteoporosis. Anabolic for bone, the opposite of bisphosphonates.
A compound studied for calming nerve pain and inflammation without raising red blood cells. An EPO-derived peptide that targets the innate-repair receptor without the red-blood-cell side of erythropoietin, studied for neuropathic pain, sarcoidosis, and diabetic complications.
A gut drug that helps people with short bowel syndrome absorb more nutrients. A recombinant GLP-2 analog, FDA-approved in 2012 for short bowel syndrome with intestinal failure; it hits a different receptor and indication than the GLP-1 weight-loss drugs.